Status:
UNKNOWN
Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Diabetic Macular Edema
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
to compare the effect of intravitreal bevacizumab alone or in combination with triamcinolone acetonide with laser photocoagulation on clinically significant macular edema (CSME)
Detailed Description
we entered 150 eyes into the study that recruitment of cases finished recently.Eligible eyes randomly assign to one of the study arms including intravitreal bevacizumzb, intravitreal bevacizumzb/triam...
Eligibility Criteria
Inclusion
- case with clear media IOP below 23 mm/Hg female after menopause at least for 12 months or had 2 contraceptive roots visual acuity between 20/50 to 20/320
Exclusion
- no PRP or N.d YAG laser in past 6 months no intraocular surgery in past 12 months
- CVA in past 12 months blood sugar above 250
- active infection in extraocular adnexa
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00370669
Start Date
November 1 2005
End Date
February 1 2007
Last Update
February 22 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Masoud Soheilian
Tehran, Tehran Province, Iran, 16666